|
Mar 8
|
Ovid Therapeutics Reports Business Updates, Fourth Quarter and Full Year 2023 Financial Results
|
|
Feb 28
|
Ovid Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference
|
|
Feb 6
|
Ovid Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
|
|
Dec 1
|
Ovid Therapeutics to Present Five Abstracts Supporting its Epilepsy Programs at the 77th American Epilepsy Society Annual Meeting (2023)
|
|
Sep 29
|
20 Countries With Highest Rate of Epilepsy
|
|
Jun 28
|
Ovid Therapeutics Expands Its Scientific Leadership Team & Appoints Chief Strategy Officer
|
|
Jun 26
|
Ovid Therapeutics Added to Russell 3000® Index
|